Madrigal Pharmaceuticals (MDGL) P/E (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Madrigal Pharmaceuticals (MDGL) P/E is -40.23. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Madrigal Pharmaceuticals (MDGL)
| Year | P/E | Change |
|---|---|---|
| 2026 | -40.23 | -11.60% |
| 2025 | -45.51 | +234.39% |
| 2024 | -13.61 | -56.66% |
| 2023 | -31.40 | +73.31% |
| 2022 | -18.12 | +210.06% |
| 2021 | -5.84 | -79.77% |
| 2020 | -28.89 | +72.57% |
| 2019 | -16.74 | -67.86% |
| 2018 | -52.09 | +72.79% |
| 2017 | -30.15 | +1286.52% |
| 2016 | -2.17 | +302.29% |
| 2015 | -0.54 | -82.50% |
| 2014 | -3.09 | -27.04% |
| 2013 | -4.23 | -52.21% |
| 2012 | -8.86 | +105.31% |
| 2011 | -4.31 | -59.83% |
| 2010 | -10.74 | N/A |
Comparison Madrigal Pharmaceuticals (MDGL) P/E with competitors
Madrigal Pharmaceuticals (MDGL) P/E is -40.23.